Loading company…
Riskpilot
← Back to search
Sign in
Get full access
PHARMAPATENT AS
AS
Active
Org 992675411
Kilahamna 8, 9415 Harstad
Business and other management consultancy activities · NACE 7020
Est. 2008
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 174K
-19% vs 2024
EBITDA margin
10.8%
-90% vs 2024
Equity ratio
96.6%
Financial strength
Net profit 2025
NOK -437K
-304% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 174K
-19%
EBITDA
NOK 19K
-90%
Net profit
NOK -437K
-304%
Total assets
NOK 2,7M
-14%
Equity
NOK 2,6M
-14%
Employees
0
—
Company information
Legal name
PHARMAPATENT AS
Org number
992675411
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
24. mai 2008
Share capital
NOK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Rådgivningstjenester og investering i eiendom og andre formueobjekter.
Contact
Address
Kilahamna 8, 9415 Harstad
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Harstad
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
NOK thousands
Item
2021
2022
2023
2024
2025
Revenue
300
368
230
216
174
Staff expenses
−65
−0
−49
−16
−118
EBITDA
222
349
146
181
19
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
222
349
146
181
19
Net financials
91
22
45
73
−451
Profit before tax
312
371
192
254
−432
Tax
46
77
32
40
5
Net profit
266
295
159
214
−437
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
2025
Total assets
2 725
3 123
2 897
3 120
2 684
Equity
2 661
2 656
2 815
3 029
2 592
Long-term debt
0
0
0
0
0
Short-term debt
64
467
82
90
92
Total debt
64
467
82
90
92
Financial ratios
5-year trend
EBITDA margin
10.8%
This company
15.8%
Market median
-32% vs market
2021
2025
Equity ratio
96.6%
This company
38.2%
Market median
+153% vs market
2021
2025
Return on equity
-16.9%
This company
18.4%
Market median
-192% vs market
2021
2025
Net profit margin
-251.4%
This company
8.1%
Market median
-3204% vs market
2021
2025
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
2021
2025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
WG
Wenche Gunvor Berg Stensen
Deputy Member
Deputy Member
2008
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JS
John Sigurd Mjøen Svendsen
Chairman
2008
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
50%
50%
2022
Unknown
Individual
50%
50%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
PHARMAPATENT AS
(this company)
PHARMASUM THERAPEUTICS AS
Board network connections
Board members of PHARMAPATENT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Wenche Gunvor Berg Stensen
Deputy Member
0 companies
John Sigurd Mjøen Svendsen
Chairman
0 companies